Smoothened Receptor Antagonists [MoA] - N0000184148
Pharmacologic Class Information
Pharmacologic Code | N0000184148 |
Pharmacologic Name | Smoothened Receptor Antagonists |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Smoothened Receptor Antagonists
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Smoothened Receptor Antagonists [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0069-0298 | Daurismo | Non-Proprietary Name: Glasdegib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1531 | Daurismo | Non-Proprietary Name: Glasdegib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
47335-303 | Odomzo | Non-Proprietary Name: Sonidegib | Capsule | Oral | Sun Pharmaceutical Industries, Inc. | ACTIVE | |
50242-140 | Erivedge | Non-Proprietary Name: Vismodegib | Capsule | Oral | Genentech, Inc. | ACTIVE |